Expertise provided by James Collins, Owner
You have watched someone you love try detox twice, residential treatment once, and six months on Suboxone. Within weeks of each attempt, they were using again. Now you are reading about ibogaine and wondering whether one treatment session can do what months of conventional care could not. This Iboga Wellness Institute guide explains ibogaine detox for opioids the way we would explain it to our own family: what it can do, what it cannot do, and how medical screening decides who is safe to treat.
The honest answer is not simple.
Ibogaine may interrupt opioid withdrawal and quiet cravings for some people, which can provide a window that some individuals have never had before. Whether that window stays open depends on medical readiness, careful screening, and what happens in the months after treatment. At Iboga Wellness Institute, a physician-led program with its licensed clinic in Cozumel, Mexico, every decision comes back to one question, the same one you are probably asking tonight: would we trust this with someone we love?
We’re not looking for a miracle. You probably aren’t either. You are looking for something real, explained by people who will tell you the truth, including when the answer is no.
Does Ibogaine Eliminate Opiate Withdrawal?
For some people, ibogaine may sharply reduce or interrupt the physical symptoms of opioid withdrawal, sometimes within about a day of treatment. That relief can be real for those who experience it, but it is not the same as lasting abstinence or freedom from cravings in the weeks and months that follow.
If you have sat with your loved one through withdrawal, you know what it looks like. The sweating and chills. The aching legs that will not stay still. The vomiting, the diarrhea, the nights without sleep, and the anxiety that makes every hour feel like ten. Withdrawal is often the wall people hit. It is the reason they leave detox early or go back to using just to feel normal, so a treatment that may soften that wall for some individuals matters.
In 2018, Noller and colleagues published a small observational study in the American Journal of Drug and Alcohol Abuse that followed people with opioid dependence who received a single ibogaine treatment in New Zealand. They reported meaningful drops in withdrawal scores shortly after treatment, along with reduced drug use for some participants over a 12-month follow-up. The study was small and had no comparison group, so it can point toward possibility but cannot promise anything.
Here is the part families are rarely told: ending acute withdrawal and ending addiction are two different things. The clinical team at Iboga Wellness Institute sees recovery split into separate threads after treatment. In one case the team has seen, a person felt their cravings had largely lifted yet still woke up exhausted, slept poorly, felt anxious, or carried lingering physical discomfort. In another, someone felt physically well in Cozumel, then walked back into their home and met emotional triggers that hit harder than expected. Every recovery is individual, and results vary. The body can feel better long before the life around it has changed.
That is why Iboga Wellness Institute treats withdrawal relief as a beginning.
The medicine may open the door for some individuals, but lasting freedom comes from the choices a person makes once they walk through it. Relationships, purpose, health, the people they spend time with, and the stress they go home to all still matter. A good program plans for all of it from the first call.
What Is Ibogaine Detox for Opioids and How Does It Work?
Ibogaine detox is a medically supervised treatment that uses a single, individually set dose of ibogaine, called a flood dose, to potentially interrupt opioid withdrawal and craving in some individuals. Ibogaine and its long-acting metabolite, noribogaine, act on several brain systems at once, including opioid, serotonin, dopamine, and NMDA receptors.
Ibogaine comes from the root bark of Tabernanthe iboga, a shrub from Central Africa long used in Bwiti ceremony. Iboga Wellness Institute brings that ancient Bwiti tradition together with modern neuroscience, and modern research has focused on what happens in the brain after a person takes it. Once ibogaine is in the body, the liver converts it into noribogaine, a compound that stays active much longer than ibogaine itself. Researchers believe this long tail may help explain reports of reduced craving for days or weeks after a single session, though individual experiences vary widely. You may read online that ibogaine “resets” dependency or supports neuroplastic healing. Those phrases capture how it can feel to some people, but the science is still developing, and no one fully understands the mechanism yet.
This multi-system action is what makes ibogaine different from the medications your loved one may already have tried. Buprenorphine, the main ingredient in Suboxone, partly activates the opioid receptor, while methadone fully activates it. Both work by replacing the drug with a steadier, safer opioid. That is why they are so effective at preventing overdose, and also why some people find them so hard to taper off. Ibogaine is not an opioid replacement. It appears to act on opioid pathways while also affecting systems tied to mood, reward, and learning. For a person who has cycled through replacement therapy and still feels trapped, that difference is often why they start asking about ibogaine.
The same broad action is also why ibogaine carries real risks, especially for the heart, and why it is never something to try casually.
At Iboga Wellness Institute, the schedule bends to the patient, not the other way around. Before anyone sets a treatment day, the team checks whether the person is medically ready, how their withdrawal is presenting, whether they are well hydrated, what their lab work shows, and what their cardiac screening reveals. When someone needs more time to stabilize or more evaluation, the plan makes room for it. Having used fentanyl tells the team to dig deeper. It does not, on its own, predict a poor result, and it is never a reason to reach for a bigger ibogaine dose.
What Drug Is Used to Detox from Opioids?
The standard medications for opioid use disorder are buprenorphine, methadone, and naltrexone. They are FDA-approved and remain the first choice for most people. Ibogaine is not FDA-approved, is a Schedule I substance in the United States, and should be considered only for people who meet strict medical criteria and have not found lasting benefit with conventional care, though individual responses to any treatment vary.
SAMHSA recognizes these three medications as the backbone of evidence-based opioid treatment, and for good reason: they are studied, regulated, and widely available. To ease withdrawal symptoms alone, doctors may also prescribe non-opioid medicines such as lofexidine or clonidine. If your loved one has never tried medication treatment, or tried it without real support, that path deserves an honest look first. Iboga Wellness Institute does not position ibogaine as a replacement for proven care. It offers ibogaine detox for opioids as a possible option for people for whom proven care has repeatedly not held.
Ibogaine sits in a different category because it is investigational. Interest is growing. In 2026, Maryland state lawmakers heard testimony on a proposed ibogaine clinical research grant program. But research interest is not approval. Families who travel for ibogaine are choosing a treatment that U.S. regulators have not cleared, and they deserve a provider who says that plainly.
Your loved one’s current medication also shapes the plan.
Methadone and extended-release opioids stay in the body much longer than heroin or short-acting pills, and methadone can affect heart rhythm on its own. For these reasons, medically supervised programs commonly plan a careful transition from long-acting opioids before ibogaine is considered. A physician decides that transition, never the family or the patient alone. The Iboga Wellness Institute team also cautions families that “pain pills” covers a lot of ground. A person on a short-acting tablet has a very different exposure history than someone on an extended-release product. And many people are sure they have been using heroin or pharmacy pills when what they were actually buying contained fentanyl. That is why the team asks for as much detail as possible about what was taken, how often, alongside other medications and overall health.
Please do not let your loved one stop methadone or buprenorphine on their own to “get ready.” Stopping suddenly can be dangerous, and it can raise overdose risk if they return to use.
What Is the Medical Clearance Process for Ibogaine Treatment?
Medical clearance for ibogaine is a step-by-step review that decides whether treatment is safe, and the heart check is the most important gate. At Iboga Wellness Institute, no one receives ibogaine until a physician has reviewed their history, cardiac testing, toxicology, and overall health.
The process at Iboga Wellness Institute moves through these steps:
- Confidential admissions consultation and history. The team learns what your loved one has been using, how often, and for how long, along with anything else in the picture: other substances, prescriptions, chronic pain, mental health history, and past treatment attempts. The goal is the most accurate picture possible of what they were really taking.
- 12-lead ECG with QTc measurement. A full electrical tracing of the heart measures the QTc interval, the time the heart needs to reset between beats. This is the single most important safety number in ibogaine care.
- Urine toxicology screening. Testing shows what substances are present. It is one piece of information, not the final word.
- Comprehensive medical screening. The team reviews laboratory results, hydration, withdrawal symptoms, and overall physical health together.
- Physician review. A physician looks at the full picture and decides whether ibogaine is medically appropriate, whether more evaluation is needed, or whether the answer is no.
- Determination of readiness. If treatment is approved, timing follows the person’s condition. If someone needs additional stabilization, the schedule adjusts to fit them.
Why does the heart matter so much? Ibogaine can slow the heart’s electrical recovery between beats, which shows up as a longer QT interval. Reviews of the research, including a recent paper on ibogaine’s therapeutic potential and cardiac safety, describe this effect as the central safety concern. A heart that already runs close to the edge can be pushed into a dangerous rhythm. At Iboga Wellness Institute, treatment does not proceed when the ECG findings fall outside what the physician considers safe, no matter how much someone wants treatment.
Toxicology needs careful reading too.
Iboga Wellness Institute points families to a small study of people entering residential treatment, which found that fentanyl and its metabolite could show up in urine far longer than many short-acting opioids would, likely because fentanyl tends to build up in body tissues with repeated use. The team is careful about what that result does and does not mean. A positive test alone cannot show whether the drug is still actively affecting someone, how hard their withdrawal will be, or when they are ready for ibogaine. Answering those questions takes a wider clinical assessment. That is why Iboga Wellness Institute does not run a fixed checklist and move on. Clinical care without compromise means safety always comes before filling a bed.
What May Disqualify Someone from Ibogaine Treatment?
Heart problems, especially a prolonged QTc interval, are the most common reason someone cannot safely receive ibogaine. Certain psychiatric disorders and active crises also rule treatment out, because in those situations the risk outweighs any possible benefit.
At Iboga Wellness Institute, these conditions may disqualify someone or delay treatment until they are resolved:
- A prolonged QTc interval on the 12-lead ECG, or other heart rhythm findings the physician considers unsafe.
- Serious cardiovascular conditions, such as significant heart disease or a history of dangerous arrhythmias. Iboga Wellness Institute does not provide ibogaine to people with serious cardiovascular conditions.
- Psychosis. Iboga Wellness Institute does not treat individuals with psychosis.
- Certain bipolar disorder presentations, which the physician evaluates during screening.
- An acute psychiatric emergency or active suicidal crisis. Ibogaine is not an emergency psychiatric intervention. A person in crisis needs emergency care first.
- Medical instability found during screening, such as laboratory or hydration problems, which may need correction before treatment can be reconsidered.
- Current medications or long-acting opioids that require a supervised transition first, including methadone, as decided by a physician.
- Unwillingness to participate. Iboga Wellness Institute does not provide forced treatment. Your loved one has to choose this for themselves.
Fentanyl history is not on that list by itself. At Iboga Wellness Institute, it calls for a more thorough assessment, not an automatic no. What fentanyl mostly changes is predictability: preparation and the first stretch of recovery can unfold less evenly than they do for someone coming off heroin or a short-acting painkiller. That does not shut the door on benefit for everyone. It means the team will not assume your loved one’s timeline matches anyone else’s.
A “no” can feel crushing when this was supposed to be the last option. Please hear it differently. A program that turns people away when screening shows real risk is protecting someone’s son, daughter, spouse, parent, sibling, or best friend. Applying or paying does not guarantee treatment at Iboga Wellness Institute, and it should not at any program. If your loved one is not a candidate, that is a reason to look closely at medication treatment and other options with a doctor, not a reason to give up. If they are in danger right now, call or text 988, or call 911.
What Has Been Reported in Research on Ibogaine and Opioid Addiction?
There is no single reliable success rate for ibogaine in opioid addiction. Small observational studies published in 2018 reported sharp drops in withdrawal and reduced opioid use for some participants afterward, but those studies were small, had no control groups, and cannot predict how any one person will do.
Two studies come up most often when families research ibogaine detox for opioids. The Noller study described earlier followed participants for 12 months and reported reduced withdrawal after treatment and lower drug use for some people over time. A second 2018 observational study by Brown and colleagues, also in the American Journal of Drug and Alcohol Abuse, tracked people treated with ibogaine at clinics in Mexico. It reported large drops in withdrawal scores, and a portion of participants reported no opioid use at the one-month follow-up, with results varying at later check-ins. These findings are encouraging. They are also early, and the people in them were not randomly assigned or compared against standard care. Neither study offers a dependable way to say whether fentanyl users do better or worse than people who used heroin or prescription opioids.
When a clinic quotes you a success rate, ask what “success” means, because it can mean very different things. It might mean getting through withdrawal without returning to use during treatment. It might mean staying off opioids for 30 days. Or it might mean staying in recovery for a full year, with work, relationships, and health rebuilt. Each one is a real milestone, and each one produces a very different number. A program that blends them together is not giving you the full picture.
Iboga Wellness Institute will not hand you a tidy percentage, and it will not quote one number for fentanyl and another for heroin when the evidence does not support that split. What the team can tell you is what may shape the outcome for some individuals: how long the dependence has lasted, other substance use, underlying pain, mental health, and the support available at home. Your loved one’s primary opioid helps the physician ask sharper questions. It does not tell the whole story.
That is why integration at Iboga Wellness Institute continues after treatment. One-on-one sessions give a person room to work through their own triggers, relationships, and concerns. Group support keeps them connected and gives them a place to speak up when they are struggling. Persistent physical symptoms or significant cravings get medical follow-up, rather than being treated only as integration issues. The longer-term goal is for your loved one to remain stable, stay engaged in care, and build a life they no longer feel the need to escape from.
How Is Ibogaine Administered for Opioid Detox?
Ibogaine is taken by mouth as a flood dose that a physician sets for the individual, in a medical setting with continuous cardiac monitoring and nursing staff present throughout. All ibogaine treatment at Iboga Wellness Institute takes place at its licensed medical clinic in Cozumel, Mexico, never at any U.S. location.
The institute operates three private settings in Cozumel, all held to one clinical standard. As a US-based institute, it offers families the American consumer protections they would expect at home. For Ohio families, the Columbus office coordinates admissions, screening, and aftercare. No ibogaine is given in Columbus or anywhere in the United States. Your first conversations and screening coordination can begin from home, before anyone books travel, and the aftercare connection continues once your loved one comes back.
The flood dose session itself often lasts somewhere between 24 and 36 hours. Your loved one stays lying down in a quiet, dim room. Many people describe a dreamlike early phase with vivid images or memories, followed by a long, reflective phase where they think through their life and choices. Nausea, unsteadiness, and sensitivity to light and sound are common, so they are not allowed to get up alone. This is not a pleasant or recreational experience. It is demanding, and people need steady care at the bedside.
That care is the point. Iboga Wellness Institute provides physician-led care with 24/7 nursing and continuous cardiac monitoring, at a 4:1 staff-to-patient ratio. Staff watch the heart in real time during the hours when ibogaine’s cardiac effects are strongest. Nobody is left alone in a room hoping things go well.
After the session, the work shifts to rest and observation. Your loved one sleeps, slowly starts eating again, and regains their balance. The Iboga Wellness Institute team watches for lingering withdrawal symptoms, sleep problems, low energy, and anxiety, because physical recovery does not finish when the acute effects fade. Integration starts while they are still in Cozumel, so the first conversations about triggers, home, and next steps happen before they get on a plane. Follow-up continues once they return, which is when the hardest days often show up.
Questions Families Ask Before They Make the First Call
These are the questions families most often bring to Iboga Wellness Institute before they decide anything. Each answer is short and honest, because you have had enough promises.
How long does ibogaine detox take for opioid addiction?
The flood dose session often lasts 24 to 36 hours under medical supervision. Preparation and post-treatment observation extend the total stay to several days or longer. At Iboga Wellness Institute, the timeline follows your loved one’s condition, so someone who needs more stabilization stays longer.
Is ibogaine safe for someone who has been using fentanyl?
At Iboga Wellness Institute, fentanyl history calls for a more thorough medical assessment and may lengthen preparation, because fentanyl can make the early period less predictable for some individuals. It is not an automatic disqualification, and it is not a reason for a larger dose. The decision rests on the full screening, especially cardiac results.
Can ibogaine treatment be done in the United States?
No. Ibogaine is a Schedule I substance in the United States and is not FDA-approved for any use. Iboga Wellness Institute provides ibogaine treatment only at its licensed clinic in Cozumel, Mexico, while its Columbus, Ohio office coordinates admissions, screening, and aftercare.
What happens if someone relapses after ibogaine treatment?
Ibogaine may interrupt withdrawal and reduce cravings for some individuals, but it cannot protect anyone from every trigger at home. A relapse is a signal to reconnect with care, not proof that the person is beyond help. One-on-one integration, group support, and medical follow-up at Iboga Wellness Institute are built for exactly that moment.
Does insurance cover ibogaine treatment for opioid detox?
Iboga Wellness Institute does not accept insurance, and most U.S. insurance plans do not cover ibogaine because it is not FDA-approved. Healing shouldn’t wait for financial readiness, so the admissions team will walk through cost and payment questions with you during the consultation, and you will know where you stand before you make any decision.
Who should not receive ibogaine treatment for opioid addiction?
People with a prolonged QTc interval, serious cardiovascular conditions, psychosis, certain bipolar disorder presentations, or an active suicidal crisis are not medically eligible. A physician makes the final call after the full screening.
Would You Trust This With Someone You Love?
Only move forward with a program that is willing to tell your loved one no if screening shows treatment is unsafe. That willingness is the clearest sign that the people on the other end are putting your loved one’s life ahead of a sale.
You have been through enough. You have driven to detox centers at midnight, signed forms, waited by the phone, and started to believe again, only to watch it fall apart. You do not need another pitch. You need a straight answer about whether ibogaine detox for opioids is medically appropriate for the person you love, and what happens before, during, and after.
Ancient wisdom. Modern science. Infinite possibilities. We are trying to be the program we would want for our own families.
Begin your journey with a confidential admissions consultation at Iboga Wellness Institute. The admissions team, coordinated through the Columbus, Ohio office, will start the comprehensive medical screening that decides whether ibogaine is safe for your loved one, and will tell you honestly if it is not. You can also read more about the Iboga Wellness Institute medical detox program before you call.
One thing you can do tonight: write down every substance and medication your loved one takes, including the exact methadone or buprenorphine dose if they are on one, whether their pills were short-acting or extended-release, and any chance their supply contained fentanyl. Gather any recent ECG or lab results they already have. Bringing that list to the first conversation helps the physician ask better questions from the very start.
Important legal and safety information: Ibogaine is not approved by the FDA and is not available as a legal medical treatment in the United States. Iboga Wellness Institute provides ibogaine treatment exclusively at its licensed medical clinic in Cozumel, Mexico, under medical supervision. US locations handle admissions, screening, and aftercare coordination only.
Ready to Learn More About Ibogaine Treatment?
If you’ve been researching alternatives to traditional opioid detox and the unique properties of ibogaine have caught your attention, our Iboga Wellness Institute admissions team can answer your specific questions about the treatment process at our licensed medical clinic in Cozumel, Mexico. We understand that considering a medically supervised ibogaine protocol is a significant decision, and we’re here to walk you through safety protocols, candidacy requirements, and what to expect before, during, and after treatment.
This article is for education and is not medical advice. Ibogaine is a Schedule I substance in the United States and is not FDA-approved. Eligibility is determined only through individual medical screening, and individual results vary.

































